Medical science has long been on the hunt for a deeper understanding of the devastating scarring of the body's organs known ...
Aileron Therapeutics, Inc. ("Aileron") (NASDAQ: ALRN), a biopharmaceutical company advancing a novel pipeline of ...
A University of Colorado professor won the 2024 Alton Ochsner Award for his work on disease risk factors for idiopathic ...
ECMO or ventilator use was the most significant predictor of mortality in patients undergoing lung transplant for idiopathic ...
The most common breast cancer is HER2-negative, so called because it has low amounts of one of the proteins that contribute ...
Fast Track Designation is available to drugs that may provide an advantage over current therapies in the treatment of serious conditions. It is designed to speed the development o ...
The most common breast cancer is HER2-negative, so called because it has low amounts of one of the proteins that contribute ...
The Hong Kong headquartered company says its idiopathic pulmonary fibrosis drug performed well in a phase 2a trial and met ...
The positive phase 3 results showed improved lung function with nerandomilast vs placebo at 52 weeks in idiopathic pulmonary ...
Insilico Medicine has announced positive preliminary results from its Phase IIa clinical trial of ISM001-055, a small ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback